doctors

Swiss pharma giant buys US sickle cell lab

Swiss-based pharmaceuticals giant Novartis said on Monday it was acquiring Selexys Pharmaceuticals Corp., a US research lab in blood and inflammatory disorders, in a deal costing up to $665 million (627 million euros).